Needham reiterated a Hold rating for ResMed (NYSE:RMD), highlighting the company's second quarter fiscal year 2025 performance. ResMed reported revenue and earnings per share (EPS) that surpassed ...

The digital health unicorn sells its chronic condition management and musculoskeletal programs to employers and health plans ...

Shares of Vertex Pharmaceuticals rose after Journavx, the company’s oral non-opioid pain medication, received Food and Drug ...

He has covered insurance for a decade, including auto, home, life and health. Before cove... Ashlee is an insurance editor, journalist and business professional with an MBA and more than 17 years ...

We recently compiled a list of the Jim Cramer Shed Light on These 9 Stocks. In this article, we are going to take a look at ...

Shares of Thermo Fisher Scientific jumped Thursday after the company's fourth-quarter results topped estimates, as sales increased across all four of its divisions.

Driven by rapid innovations and the integration of modern technologies, the biotech sector is experiencing robust growth.

Avior Wealth Management LLC bought a new stake in shares of Lemonade, Inc. (NYSE:LMND – Free Report) in the 4th quarter, ...

Me (ME) forms special board committee to explore strategic alternatives, including sale, restructuring, or business ...

Aaaa Aaaaa Aaaa 114.21 +23.02% ...

In our analysis, these 12 brokerage accounts stand out as the best choices for stock trading, due to their low fees, strong platforms and quality customer support. Many, or all, of the products ...

Me still merchandises its ancestry, health analysis, and the Total Health annual package on a scale from $99 to $999 annually. Lemonaid entered the hot GLP-1 prescribing and support business in 2024, ...